Uncategorized

Pubgene’s digital health COREMINE Vitae™ obtained CE-mark

PubGene’s digital health platform for personalised medicine, Coremine Vitae, obtained the CE-mark Class I Medical Device, ensuring that it complies with all the relevant Essential Requirements of the Medical Devices Directive – 93/42/EEC MDD and subsequent amendments. 

Coremine Vitae applied on neuro diseases

PubGene has conducted a first Coremine Vitae within the neuro diseases. We successfully provided an epilepsy patient with information on disease characteristics and drugs.   

Coremine Medical upgrade

The Coremine Medical service is upgraded with new features. Please register to the service here: https://coremine.com/medical/